I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 35% ± 19% | |
| endothelial cell | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 35% ± 19% | |
| endothelial cell | 3 studies | 24% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 24% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 4879.04 | 1445 / 1445 | 100% | 23.84 | 183 / 183 |
| prostate | 100% | 4712.08 | 245 / 245 | 100% | 24.18 | 502 / 502 |
| thymus | 100% | 5134.79 | 653 / 653 | 100% | 22.02 | 604 / 605 |
| intestine | 100% | 5339.83 | 966 / 966 | 100% | 17.04 | 525 / 527 |
| brain | 100% | 7903.18 | 2634 / 2642 | 100% | 28.03 | 703 / 705 |
| skin | 100% | 4576.23 | 1809 / 1809 | 99% | 22.38 | 469 / 472 |
| stomach | 100% | 4027.94 | 359 / 359 | 99% | 18.70 | 283 / 286 |
| breast | 100% | 4609.06 | 459 / 459 | 99% | 21.33 | 1104 / 1118 |
| ovary | 100% | 4140.90 | 180 / 180 | 99% | 15.30 | 424 / 430 |
| pancreas | 100% | 2652.43 | 327 / 328 | 99% | 18.06 | 176 / 178 |
| lung | 100% | 5552.20 | 578 / 578 | 98% | 16.33 | 1137 / 1155 |
| kidney | 100% | 4015.70 | 89 / 89 | 98% | 19.11 | 883 / 901 |
| bladder | 100% | 4695.43 | 21 / 21 | 98% | 14.93 | 493 / 504 |
| uterus | 100% | 5195.45 | 170 / 170 | 97% | 13.67 | 445 / 459 |
| adrenal gland | 100% | 4112.24 | 258 / 258 | 96% | 20.83 | 221 / 230 |
| liver | 99% | 1983.65 | 223 / 226 | 74% | 7.14 | 301 / 406 |
| adipose | 100% | 4406.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 4947.58 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 22.87 | 80 / 80 |
| muscle | 100% | 6049.24 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 6071.41 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 5.64 | 1 / 1 |
| peripheral blood | 99% | 4276.17 | 918 / 929 | 0% | 0 | 0 / 0 |
| heart | 99% | 3053.27 | 849 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 17.60 | 28 / 29 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 14.36 | 43 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0014898 | Biological process | cardiac muscle hypertrophy in response to stress |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0003690 | Molecular function | double-stranded DNA binding |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0042826 | Molecular function | histone deacetylase binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0043565 | Molecular function | sequence-specific DNA binding |
| GO_0003712 | Molecular function | transcription coregulator activity |
| GO_0003682 | Molecular function | chromatin binding |
| Gene name | CAMTA2 |
| Protein name | Calmodulin binding transcription activator 2 Calmodulin-binding transcription activator 2 CAMTA2 protein |
| Synonyms | KIAA0909 |
| Description | FUNCTION: Transcription activator. May act as tumor suppressor. . |
| Accessions | ENST00000381311.9 [O94983-3] ENST00000574951.5 I3L146 ENST00000573004.5 ENST00000574606.2 ENST00000414043.7 [O94983-6] O94983 ENST00000361571.9 [O94983-4] I3L3V0 ENST00000572543.5 ENST00000348066.8 [O94983-1] B7ZM30 I3L3W6 I3L2A1 B2RZG4 A5PL10 |
